MDPV (methylenedioxypyrovalerone)

An alpha-pyrrolidinyl cathinone acting primarily as a dopamine/noradrenaline reuptake inhibitor. Central to the US 'bath salts' crisis 2011-2012; substantially more potent and more likely to produce psychosis than mephedrone. Schedule I US since 2011.